JVMIX
Price
$31.91
Change
-$0.13 (-0.41%)
Updated
Sep 4 closing price
Net Assets
23.81B
MCMVX
Price
$24.67
Change
-$0.00 (-0.00%)
Updated
Sep 4 closing price
Net Assets
48.29M
Interact to see
Advertisement

JVMIX vs MCMVX

JVMIX vs MCMVX Comparison Chart in %
View a ticker or compare two or three
VS
JVMIX vs. MCMVX commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMIX is a Hold and MCMVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMIX has more cash in the bank: 23.8B vs. MCMVX (48.3M). MCMVX pays higher dividends than JVMIX: MCMVX (0.99) vs JVMIX (0.65). JVMIX was incepted earlier than MCMVX: JVMIX (29 years) vs MCMVX (13 years). MCMVX (1.60) is less costly to investors than JVMIX (0.86). JVMIX is a more actively managed with annual turnover of: 48.00 vs. MCMVX (37.00). MCMVX has a lower initial minimum investment than JVMIX: MCMVX (5000) vs JVMIX (250000). MCMVX annual gain was more profitable for investors over the last year : 18.87 vs. JVMIX (6.56). MCMVX return over 5 years is better than : 32.01 vs. JVMIX (16.54).
JVMIXMCMVXJVMIX / MCMVX
Total Expense Ratio0.850.8699%
Annual Report Gross Expense Ratio0.861.6054%
Fund Existence29 years13 years-
Gain YTD16.16320.04981%
Front LoadN/AN/A-
Min. Initial Investment25000050005,000%
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B48.3M49,275%
Annual Yield % from dividends0.650.9966%
Returns for 1 year6.5618.8735%
Returns for 3 years24.3446.1053%
Returns for 5 years16.5432.0152%
Returns for 10 years59.48130.8145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIOSX18.170.07
+0.39%
Nuveen International Opps A
IVNQX60.290.14
+0.23%
Invesco Nasdaq 100 Index R6
MAIIX22.19-0.02
-0.09%
iShares MSCI EAFE Intl Idx Instl
NWAOX42.29-0.17
-0.40%
Nationwide BNY Mellon Dyn US Eq Inc I.S
SRFMX12.63-0.06
-0.47%
Sarofim Equity